Ex vivo delivery of suicide genes into melanoma cells using epidermal growth factor receptor-specific Fab immunogene

Yuichiro Ohtake, Jiabing Chen, Shinobu Gamou, Atsushi Takayanagi, Yukihiko Mashima, Yoshihisa Oguchi, Nobuyoshi Shimizu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The Fab fragment of monoclonal antibody B4G7 against human epidermal growth factor (EGF) receptor was conjugated with cationic poly-L-lysine and the resulting conjugate was further complexed with reporter genes or therapeutic genes. This Fab/DNA complex was designated as 'Fab immunogene.' The Fab immunogene transfer in vitro was mediated through the EGF receptors in two melanoma cell lines. The frequency of cells expressing β-galactosidase (βGal) reporter gene was approximately 1%. The induction of suicide effects after Fab immunogene transfer of herpes simplex virus thymidine kinase (TK) or Escherichia coli cytosine deaminase (CD) gene was quite remarkable, and the growth of melanoma cells was inhibited for over 7 days in the presence of ganciclovir (GCV) or 5-fluorocytosine (5-FC). Similarly, when melanoma cells treated in vitro with the Fab immunogene carrying TK or CD were transplanted into the back of nude mouse, subsequent systemic administration of GCV or 5-FC effectively suppressed the growth of tumors, indicating the occurrence of in vivo suicide effects.

Original languageEnglish
Pages (from-to)460-468
Number of pages9
JournalJapanese Journal of Cancer Research
Volume90
Issue number4
Publication statusPublished - 1999 Apr

    Fingerprint

Keywords

  • Anti-EGF receptor antibody
  • Endocytosis
  • Gene therapy
  • Immunogene
  • Melanoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ohtake, Y., Chen, J., Gamou, S., Takayanagi, A., Mashima, Y., Oguchi, Y., & Shimizu, N. (1999). Ex vivo delivery of suicide genes into melanoma cells using epidermal growth factor receptor-specific Fab immunogene. Japanese Journal of Cancer Research, 90(4), 460-468.